Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Kabuki syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Kabuki syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
CHARGE syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 CHARGE syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
22q11.2 deletion syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 22q11.2 deletion syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Pierre Robin sequence Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Pierre Robin sequence strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Treacher Collins syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Treacher Collins syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Empty sella-associated CSF rhinorrhea Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Empty sella-associated CSF rhinorrhea strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Chronic smell loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Chronic smell loss indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Congenital anosmia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Congenital anosmia indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Post-viral olfactory dysfunction Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Post-viral olfactory dysfunction strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Facial nerve palsy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Facial nerve palsy indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Ramsay Hunt syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Ramsay Hunt syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Mal de debarquement syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Mal de debarquement syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.